The Share

Novakand Pharma’s share has been traded on Nasdaq OMX First North Premier since October 31, 2016. The company’s shares are traded with the short name NOVKAN and the ISIN code SE0003622265.

Dividend policy

The size of future possible dividends to holders of shares in Novakand Pharma depends on a number of factors, such as earnings, financial position, cash flow and working capital requirements. Only when long-term profitability can be predicted via the launch of products on the market will dividends to shareholders be possible. In the next few years, therefore, no dividend will be paid.

Insider information

This is handled in accordance with legislation that entered into force on 3 July 2016 (Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse (s) and reported directly to Finansinspektionen. For more information, see Finansinspektionen’s website www.fi.se.